Sponsors / SVRA
SVRA

Savara Inc.

Company identity checked against sources

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
4Trials in this database
2Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
Pilot Trial of Inhaled Molgramostim in Non-tuberculous Mycobacterial (NTM) InfectionNCT03421743SVRAPhase 2Completed2019-10-15Actual
Safety Extension Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar ProteinosisNCT03482752SVRAPhase 3Terminated2021-01-14Actual
Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)NCT04544293SVRAPhase 3Active not recruiting2023-11-30Actual
Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).NCT06431776SVRAPhase 3Recruiting2027-06Estimated

Latest recorded trial changes